$HSTM

REBROVICK LINDA sold $50K of HSTM

REBROVICK LINDA sold 2,000 shares of HEALTHSTREAM INC (HSTM) at $25.00 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · REBROVICK LINDA
Published Jun 2, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HSTM
Neutral
medium confidence
Mentioned
$HSTM
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HSTMNeutralLow
01

Why it matters

The only new information is the disclosed sale details (2,000 shares at $25.00, $50,000 total) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and modest transaction value reduce the signal strength.

03

What to watch

The filing does not disclose any new company-specific fundamentals, and the post-transaction holdings (54,181 shares) suggest the director remains a meaningful holder.

Relevance 2/10Novelty 3/10Timing: SEC Form 4 filed 2026-06-02 for a 2026-06-01 sale

Background

The article is an SEC Form 4 insider transaction disclosure for HealthStream (HSTM) by director Linda Rebrovick.

Company-level read

Ticker impact

$HSTMNeutralMedium confidence
Context

HealthStream director Linda Rebrovick sold 2,000 shares in an open-market transaction on 2026-06-01 under a 10b5-1 plan, totaling $50,000.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the disclosed sale size is relatively small versus typical large-cap trading flows.

Market effects

No clear sector read-through from a single, small 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • HEALTHSTREAM INC

    US-listed company whose director insider sale is disclosed via Form 4.

  • REBROVICK LINDA

    Director who sold 2,000 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HSTMMed

WJRJJ Ventures Discloses Investment at HealthStream with 9.6% Stake

WJRJJ Ventures disclosed a 9.6% stake in HealthStream, acquired through open-market buys and a deal at $29.50 per share. The investment includes a one-year standstill and registration rights. WJRJJ plans to hold shares for investment but may buy or sell more over time. Willis Johnson, managing member of WJRJJ, is involved in the investment.

$HSTMHigh

HEALTHSTREAM ANNOUNCES SECOND QUARTER 2026 RESULTS

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. HealthStream Announces Second Quarter 2026 Results Page 1 August 3, 2026 Exhibit 99.1 Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Head, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstre